Heterocyclic compounds as immunomodulators
US11673883B2 · kind B2 · utility
9Cited by
37References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Oct 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.